Skip to Content

Amphastar Pharmaceuticals Inc AMPH

Morningstar Rating
$46.70 +0.48 (1.04%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AMPH is trading at a 11% discount.
Price
$46.19
Fair Value
$91.16
Uncertainty
High
1-Star Price
$64.75
5-Star Price
$85.21
Economic Moat
Hgzdrc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AMPH is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$46.22
Day Range
$45.4946.96
52-Week Range
$34.7867.66
Bid/Ask
$45.58 / $48.00
Market Cap
$2.24 Bil
Volume/Avg
620,848 / 488,241

Key Statistics

Price/Earnings (Normalized)
14.01
Price/Sales
3.80
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
2.62%

Company Profile

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
1,615

Comparables

Valuation

Metric
AMPH
300108
RJF
Price/Earnings (Normalized)
14.01
Price/Book Value
3.470.96
Price/Sales
3.804.86
Price/Cash Flow
11.79
Price/Earnings
AMPH
300108
RJF

Financial Strength

Metric
AMPH
300108
RJF
Quick Ratio
1.650.100.83
Current Ratio
2.170.251.42
Interest Coverage
7.110.014.80
Quick Ratio
AMPH
300108
RJF

Profitability

Metric
AMPH
300108
RJF
Return on Assets (Normalized)
14.76%−11.67%1.43%
Return on Equity (Normalized)
30.28%2.47%
Return on Invested Capital (Normalized)
19.61%−11.91%2.24%
Return on Assets
AMPH
300108
RJF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AWfdv$87.4 Bil
MKKGY
Merck KGaA ADRQckzlb$74.3 Bil
HLN
Haleon PLC ADRCkhs$38.5 Bil
VTRS
Viatris IncDhqk$15.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRQqbvh$12.4 Bil
CTLT
Catalent IncBprqfpt$10.3 Bil
CURLF
Curaleaf Holdings IncGnmd$3.6 Bil
PRGO
Perrigo Co PLCQrxw$3.6 Bil
PBH
Prestige Consumer Healthcare IncGqtggs$3.5 Bil
GTBIF
Green Thumb Industries IncZyc$3.1 Bil

Sponsor Center